Organized by the European Laboratory Research & Innovation Group (ELRIG), the Therapeutics Oligonucleotides 2025 meeting takes place in Mölndal, Sweden on May 14-15.
Oligonucleotide-based drugs, including ASOs and siRNAs, are already significantly impacting patients’ lives. The conference will focus on drug targets amenable to modulation by oligonucleotides, recent advancements in broadening the application of oligonucleotide-based drug, including innovative approaches to ensure safety and efficacy and the use of targeted delivery to reach disease-relevant tissues, as well as clinical advancements for therapeutic oligonucleotides.
At the meeting, we will present a poster titled:
Detection of acute and delayed onset toxicity effects of ASOs using in vitro neuronal models
Poster board: 30
If you are interested in learning more about Cellectricon’s neuroscience drug discovery services, stop by the poster or reach out to setup a meeting with our onsite team.
Jennie Svensson Dalén
Director of Marketing
Meet us at Therapeutic Oligos 2025!
We are looking forward to taking part in this year’s meeting and for the opportunity to introduce our drug discovery services to prospective new partners. Get in touch if you are interested in setting up a meeting!